American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023
Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023
Texas Lung Cancer Conference Austin, TX 30March – 1April 2023
Lung Science Conference European Respiratory Society Estoril, Portugal 9-12 March 2023
AAAAI (American Academy of Allergy, Asthma and Immunology) Annual Meeting San Antonio, TX 24-27 February 2023
3rd European BronchiectasisMilan, Italy 23-25 February 2023
IVD Clinical & Regulatory Affairs Conference San Diego, CA 7-8 February 2023
Biotech Showcase, BIO Partnering at JPM San Francisco, CA 9-11 January 2023
ProAxsis announces that two of its products, the ProteaseTag® Active NE Immunoassay, and NEATstik®, the first test to enable measurement of active neutrophil elastase at point-of-care, have been selected for inclusion in a major upcoming clinical trial. The BRIDGE study is a 3-year collaborative study, funded by the European Respiratory Society (ERS), in which1000 patients with bronchiectasis across Europe will be recruited and will have multiple assessments including microbiome,proteomics, detailed phenotyping and imaging. The study will explore novel biomarkers and demonstrate what they can add to clinical practice. (Sept 2018)
ProAxsis declared as the “Innovative Business of the Year” at the Business Eye First Trust Awards (BEFTAs) for small businesses in Northern Ireland. The awards ceremony took place May 31st in Belfast, and was compered by the UTV newsreader and Northern Ireland correspondent for ITV, Marc Mallett. Over 50 Northern Irish businesses were shortlisted across the 14 award categories. The ProAxsis team were announced as the Innovative Business of the Year by Tina McKenzie, the Chair of the Federation of Small Businesses NI, who sponsored the innovation category. (June 2018)
